围术期宿主反应优化改善超低位前切除术后功能恢复与生存:随机对照试验
该单中心随机对照试验纳入194例I-III期低位直肠腺癌行根治性超低位前切除术患者,比较标准ERAS与ERAS联合围术期宿主反应优化方案。结果显示干预组术后第7天炎症标志物显著降低、功能恢复更快、住院更短,24个月无病生存率和总生存率均更高。
要点
- 围术期宿主反应优化可减轻术后全身炎症并加速功能恢复
- 干预组24个月无病生存率和总生存率均优于标准ERAS组
- 多变量Cox模型显示干预与无病生存和总生存改善独立相关
核心结论
- 针对宿主炎症和应激反应的整合围术期优化可显著改善超低位前切除术后功能恢复,并与更优的无病生存和总生存相关。
研究设计与样本
- 单中心随机对照试验,194例I-III期低位直肠腺癌行根治性超低位前切除术患者,随机分配至标准ERAS护理或ERAS联合整合围术期宿主反应优化方案。
主要发现
- 干预组术后第7天C反应蛋白、白细胞介素-6和肿瘤坏死因子-α均显著降低(均P < .001)。
- 干预组肠功能恢复更快、住院时间更短,肠道、睡眠、心理和性功能恢复显著改善并超过预设最小临床重要差异阈值。
- 24个月无病生存率干预组92.8% vs 对照组77.3%,总生存率95.9% vs 83.5%。
- 多变量Cox模型调整年龄、TNM分期、基线抑郁症状和术后炎症标志物后,干预与无病生存改善独立相关(HR 0.44;95%CI 0.22-0.87),与总生存改善独立相关(HR 0.39;95%CI 0.17-0.89)。
临床怎么用
- 对行超低位前切除术的低位直肠癌患者,可在ERAS基础上整合针对应激调节、睡眠正常化和个体化营养支持的围术期宿主反应优化策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ultra-low anterior resection for low rectal cancer is associated with profound perioperative physiologic stress and systemic inflammation, contributing to impaired functional recovery and adverse long-term outcomes. Whether the perioperative host response can be effectively modulated to improve both recovery and survival remains unclear. METHODS: In this single-center, randomized controlled trial, 194 patients with stage I-III low rectal adenocarcinoma undergoing curative ultra-low anterior resection were assigned to standard enhanced recovery after surgery care or enhanced recovery after surgery plus an integrated perioperative host-response optimization program. The intervention combined structured perioperative optimization strategies targeting stress regulation, sleep normalization, and individualized nutritional support, delivered from the preoperative period through postoperative month 6. Primary outcomes included postoperative functional recovery, assessed by validated measures of bowel, sleep, psychological, and sexual function. Secondary outcomes comprised postoperative inflammatory markers (C-reactive protein, interleukin-6, and tumor necrosis factor-α), short-term recovery metrics, and 24-month disease-free survival and overall survival. RESULTS: Compared with standard enhanced recovery after surgery care, the intervention group demonstrated significantly attenuated systemic inflammation on postoperative day 7 (C-reactive protein, interleukin-6, and tumor necrosis factor-α; all P < .001), accompanied by a faster return of bowel function and a shorter hospital stay. Functional recovery across bowel, sleep, psychological, and sexual domains was significantly improved and exceeded prespecified minimal clinically important difference thresholds. At 24 months, disease-free survival was 92.8% in the intervention group vs 77.3% in controls, and overall survival was 95.9% vs 83.5%, respectively. In multivariable Cox models adjusted for age, TNM stage, baseline depressive symptoms, and postoperative inflammatory markers, the intervention was independently associated with improved disease-free survival (hazard ratio, 0.44; 95% confidence interval, 0.22-0.87) and overall survival (hazard ratio, 0.39; 95% confidence interval, 0.17-0.89). CONCLUSION: Integrated perioperative optimization targeting the host inflammatory and stress response significantly improves functional recovery and is associated with superior disease-free survival and overall survival after ultra-low anterior resection for rectal cancer. These findings support perioperative host-response modulation as a clinically actionable strategy to enhance both short- and long-term surgical outcomes.
引用
- Pan S, Wang G. Integrated perioperative host-response optimization improves functional recovery and survival after ultra-low anterior resection: A randomized controlled trial. Surgery. 2026. PMID: 42092267. doi:10.1016/j.surg.2026.110224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。